New Study Demonstrates Adding ‘Singulair’ To Children’s Usual Asthma Treatment Halves The Number Of Days They Experience Worsened Astma Symptoms
The short term addition of ‘Singulair’® (montelukast) to usual asthma therapy for six weeks after school return could substantially reduce asthma morbidity and unscheduled physician visits during this predictably high-risk period1.
